Efrain Gutierrez-Lanz

ERG amplification is a secondary recurrent driver event in myeloid malignancy with complex karyotype and TP53 mutations

L. Shao, D. Bixby, Hong Xiao, 2022, Genes, chromosomes & cancer.

Cyclophosphamide treatment in active multiple sclerosis

J. Flores-Rivera, Adriana Casallas-Vanegas, E. Gómez‐Figueroa, 2021, Neurological Sciences.